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Objectives: To determine the degree of interinstitutional transfusion practice
variation and reasons why red cells are administered in critically ill patients.
Study design: Multicentre cohort study combined with a cross-sectional survey
of physicians requesting red cell transfusions for patients in the cohort.
Study population: The cohort included 5298 consecutive patients admitted to
six tertiary level intensive care units in addition to administering a survey to 223
physicians requesting red cell transfusions in these units.
Measurements:  Haemoglobin concentrations were collected, along with the
number and reasons for red cell transfusions plus demographic, diagnostic,
disease severity (APACHE II score), intensive care unit (ICU) mortality and
lengths of stay in the ICU.
Results: Twenty five per cent of the critically ill patients in the cohort study
received red cell transfusions. The overall number of transfusions per patient-day
in the ICU averaged 0.95±1.39 and ranged from 0.82±1.69 to 1.08±1.27
between institutions (P<0.001). Independent predictors of transfusion
thresholds (pre-transfusion haemoglobin concentrations) included patient age,
admission APACHE II score and the institution (P<0.0001). A very significant
institution effect (P < 0.0001) persisted even after multivariate adjustments for
age, APACHE II score and within four diagnostic categories (cardiovascular
disease, respiratory failure, major surgery and trauma) (P<0.0001). The
evaluation of transfusion practice using the bedside survey documented that
35% (202 of 576) of pre-transfusion haemoglobin concentrations were in the
range of 95–105g/l and 80% of the orders were for two packed cell units. The
most frequent reasons for administering red cells were acute bleeding (35%)
and the augmentation of O2 delivery (25%).
Conclusions: There is significant institutional variation in critical care transfusion
practice, many intensivists adhering to a 100g/l threshold, and opting to
administer multiple units despite published guidelines to the contrary. There is a
need for prospective studies to define optimal practice in the critically ill.
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Introduction
Physicians commonly used a threshold of 100g/l (haemat-
ocrit of 30%) as the level for transfusion of allogeneic red
cells. Adams and Lundy [1], in 1941, recommended the
administration of red cells for haemoglobin concentrations
ranging from 80 to 100g/l in the perioperative period.
Although scientific evidence supporting this approach has
been advanced, one of the most important reasons for the
selection of 100g/l as a threshold may be that it is an easily
remembered figure [2,3]. Prompted by concerns overtransfusion-related infections, recent guidelines empha-
size that the decision to transfuse should not be deter-
mined by a single haemoglobin concentration [4–6].
However, surveys of transfusion practices have repeatedly
documented the importance attributed to haemoglobin
triggers. In 1982, 88% of anaesthesiologists surveyed
believed preoperative haemoglobin levels of 90g/l to be
mandatory [7].
The decision to transfuse a critically ill patient is complex
and may be influenced by factors such as age, medica-
tions, disease severity and specific diagnoses such as acute
coronary ischaemia. Neither the importance of a specific
transfusion threshold nor the clinical characteristics that
influence transfusion practice have been documented in
this high-risk patient population. This study was therefore
designed to characterize actual transfusion practice, to
determine whether there is any significant institutional
practice variation and reasons why red cells are adminis-
tered in critically ill patients.
Methods
Study design
We implemented two concurrent and complementary data
gathering approaches. First, patients admitted to one of
six Canadian tertiary level intensive care units (ICUs)
during 1993 were enrolled in a combined retrospective
and prospective cohort study and, second, a bedside ques-
tionnaire was completed by physicians requesting blood
transfusions during the prospective phase of the cohort
study.
Study population and data collection
The cohort study included all patients admitted to one of
the six participating ICUs during the 1993 calendar year.
Patients who were less than 16 years of age or who were
considered brain dead within 24h of admission were
excluded. We collected demographic and transfusion-
related information as well as data on patient outcomes
and disease severity. The lowest overall haemoglobin con-
centration in patients who were not transfused or the
haemoglobin concentration recorded prior to the adminis-
tration of red cells in patients receiving blood were
labelled pre-transfusion haemoglobin and were used as
the primary outcome in the study.
In the prospective phase of the cohort, a bedside ques-
tionnaire was administered to all physicians requesting red
cell transfusions. To identify potential respondents, physi-
cian order forms from patient charts were screened daily.
Physicians who wrote transfusion orders were asked if
they initiated the request or if another physician
requested the administration of red cells. Physicians
requesting the transfusion were then asked to identify the
most important reason for the administration of red cells
from a list of nine possible choices: age, disease severity,
acute bleeding or ongoing blood loss, haemodynamic
instability, severe hypoxaemia, improvement in wound
healing and wellbeing, augmentation of O2 delivery, coro-
nary ischaemia, and others. The predominantly physiolog-
ical choices were identified. Each bedside questionnaire
was administered within 24h of the request for a transfu-
sion. For patients receiving multiple transfusion episodes
in a 24-h period only the first request was analysed. In
addition to the questionnaire responses and information
from the cohort study, we recorded the pre- and post-
transfusion haemoglobin concentrations and the level of
training of respondents.
Sample size considerations
The size of the cohort study was based on pre-transfusion
haemoglobin concentrations as an outcome. An analysis of
variance (ANOVA) was used to test the equality of mean
pre-transfusion haemoglobin concentrations in four age
ranges, two APACHE II ranges, transfusion status
(received or did not receive red cells) and six hospitals.
Using an F-test for the comparison of these four variables,
a level of significance a=0.05, a power of 80%, a number
of multiple comparisons and subgroup analyses, we esti-
mated that a total sample size of 4500 patients would be
required. Based on previous ICU admission rates, one year
of admissions in six critical care units was expected to
identify approximately 5000 patients.
Statistical analysis
Descriptive statistical analyses were performed on all vari-
ables in each component of this study. In the cohort study,
categorical variables including age ranges (<30 years,
30–49 years, 50–69 years, ³70 years), gender, APACHE II
categories (15 or less, greater than 15), diagnostic cate-
gories, the number of red cell units administered per
patient (0 units, 1–3 units, 4–6 units, 7–9 units, 10 or more
units) and mortality rates were initially compared amongst
institutions using chi-square test procedures. Pre-transfu-
sion haemoglobin concentrations in each patient, the
number of red cell units transfused per patient-day and
lengths of stay between institutions were compared using
a one-way ANOVA. A preliminary analysis of the influ-
ence of diagnostic categories on the administration of red
cells was evaluated using a chi-square statistic.
Pre-transfusion haemoglobin was used as the primary
outcome in the multivariate analysis. To determine how
transfusion status (received or did not receive red cells),
the institution as well as previously defined age ranges
and APACHE II categories influenced pre-transfusion
haemoglobin concentrations, we performed a four-way
ANOVA. A similar ANOVA was performed for specific
disease categories including multiple trauma, respiratory
diseases, cardiovascular diseases and postoperative
patients in order to control for the influence of disease cat-
egories on transfusion thresholds.
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response rate at each institution by cross checking
recorded transfusions in the cohort study with the com-
pleted questionnaires. The term ‘transfusion threshold’
was defined as the pre-transfusion haemoglobin concen-
tration recorded in the bedside questionnaire. Chi-square
procedures were employed to test relationships between
the nine clinical factors and other variables such as trans-
fusion thresholds and diagnostic categories as well as the
level of training of physicians responding to the question-
naire. In this study, no adjustments were made for multi-
ple comparisons. Data are reported as means±standard
deviations (SD) unless otherwise stated.
Results
Cohort study
We enrolled 5298 consecutive patients from six tertiary
level ICUs in the cohort study; 3079 patients were identi-
fied by a retrospective review of health records and 2219
patients were prospectively enrolled at the time of ICU
admission. The number of patients from each institution
ranged from 672 to 1355 (Table 1). Age, diagnostic cate-
gories and gender were comparable from institution to
institution (P>0.53); however, disease severity as indi-
cated by APACHE II scores, ICU length of stay and mor-
tality rates were significantly different between
institutions (P<0.001).
Overall, 1650 patients (25% ranging from 12% to 35%
among institutions) of 5032 critically ill patients received
red cell transfusions. There were significant differences in
the proportion of patients transfused in the different
centres using both an unadjusted chi-square statistic
(P=0.001) and a Mantel-Haenszel chi-square procedure
stratified for high and low APACHE II scores (P<0.001).
The total number of transfusions per patient-day in the
ICU ranged from 0.82±1.69 to 1.08±1.27 among institu-
tions (P<0.001) (Table 2).
Average pre-transfusion haemoglobin concentrations up
until discharge or the first 10 days in ICU (Fig 1) also dif-
fered significantly from institution to institution. ranging
from 87g/l to 95g/l (P=0.0001). Independent predictors of
average pre-transfusion haemoglobin and the number of
transfusions per patient-day included age, APACHE II
score, transfusion status and the institution (P<0.0001).
The influence of the institution remained significant
(P<0.0001) even after performing multivariate adjust-
ments for age ranges, transfusion status and APACHE II
categories. We observed a series of significant second- and
third-order interactions from the overall multivariate
analysis examining pre-transfusion haemoglobin concen-
trations (P<0.05). The most complex interaction noted
was between transfusion status, APACHE II score and the
institution (Fig 2). Significant variations in pre-transfu-
sion haemoglobin concentrations were observed in both
APACHE II categories (P<0.0001) as well as in the trans-
fused and non-transfused patients across all institutions
(P<0.0001). Institutions 3 and 6, with the lowest overall
pre-transfusion haemoglobin concentrations, also had the
least amount of change in these concentrations between
the high and the low APACHE II categories.
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Table 1
Characteristics of patients included in the cohort study
Institution
Variable* 1 23456 Overall P
Number of patients 1355 916 672 851 708 796 5298
Demographics
% Male 59 57 64 60 58 57 59 P>0.05
Age (in years±sd) 59±17.8 60±18.1 60±15.6 58±19.3 51±18.8 55±19.8 57±17.9 P>0.05
Diagnostic categories (%)
Trauma 8 7 2 14 17 12 10 P>0.05
Respiratory 13 17 11 12 37 22 18
Cardiovascular 55 31 30 24 17 24 33
Postoperative 3 13 31 1 8 11 10
Other 21 32 26 49 21 31 29
Admitting service (%)
Medical 70 38 6 46 41 53 45 P<0.05
Surgical 30 62 94 54 59 47 55
Outcomes
APACHE II Score 14±9 20±12 14±11 21±8 26±10 14±8 18±11 P<0.001
ICU length of stay (days)4.6±14.2 3.7±5.3 5.3±23.1 5.5±9.5 5.8±8.9 3.9±6.8 4.8±12.6 P<0.001
ICU Mortality(%) 17 21 19 26 31 23 22 P<0.001
*Variables reported as means±SD unless otherwise stated. ICU, intensive care unit.Significant institution (P<0.0001) and transfusion status
(P<0.0001) effects were also observed in all four diagnos-
tic categories following similar multivariate statistical pro-
cedures. APACHE II groups in patients admitted with
respiratory failure (P<0.0001), following a cardiac event
(P<0.0001) and following multiple trauma (P=0.055) pre-
dicted pre-transfusion haemoglobin values. Age (P=0.009)
but not APACHE II (P=0.84) groupings were predictive
in postoperative patients. Second-order interactions
included ‘transfusion by institution’ effects in trauma
(P=0.021) and postoperative (P=0.0005) patients. There
were no significant third- or fourth-order interactions.
Bedside questionnaire
The bedside questionnaire was administered following
758 of 1459 (52%) consecutive transfusion orders written
by 223 physicians for 386 patients. ICU staff as opposed to
consultant staff requested over 90% of the red cell transfu-
sions. Most of the transfusions were requested by junior
(26%) or senior (46%) residents. Thirty-five per cent of
pre-transfusion haemoglobin values were in the range
95–105g/l and 80% of the orders were for two packed cell
units. Post-transfusion, 30% of haemoglobin concentra-
tions were greater than 110g/l. The commonly stated
reasons for requesting red cells by ICU physicians were:
60 Critical Care 1999, Vol 3 No 2
Table 2
Transfusion related data from each institution, APACHE II groups, and age ranges among patients who received and did not
receive red cell transfusions
Institution
Variable 1 2 3 4 5 6 Overall
Number of patients 1355 916 672 851 708 796 5298
No. of transfusions (%)
Not transfused 88 70 68 65 65 82 75
1–3 units 7 19 17 16 16 9 13
4–6 units 3 6 8 9 8 5 6
7–9 units 1 2 3 4 3 1 2
³10 units 1 3 4 6 8 3 4
No. of units/patient-days 0.82±1.68 0.88±1.12 0.94±1.58 1.08±1.27 0.96±1.54 1.04±1.06 0.95±1.39
Haemoglobin concentrations (g/l)*†
Transfusion episodes 85±14.0 88±13.8 81±10.7 87±13.8 90±11.6 80±14.7 86±13.3
(n=2758)
APACHE II
³15 (n=2126) 83±14.4 87±14.1 81±11.5 85±13.1 90±11.7 80±14.5 86±13.4
<15 (n=632) 88±12.3 89±12.5 81±9.7 95±15.8 87±9.6 79±14.9 85±13.0
Diagnostic categories
Trauma (n=405) 88±18.0 82±11.2 83±10.0 90±17.5 89±14.8 80±8.2 88±13.6
Respiratory (n=525) 87±14.2 83±17.7 78±7.7 90±13.7 86±11.6 86±11.8 86±11.8
Cardiovascular (n=317)82±9.7 82±19.1 73±20.7 75±17.6 85±10.6 72±16.3 80±21.8
Postoperative (n=230) 85±12.5 87±13.4 79±11.9 89±18.4 95±13.2 86±14.3 87±14.1
No transfusion episodes 119±21.0 111±21.0 101±16.0 109±16.0 114±22.0 108±22.0 112±21.8
(n=2971)
APACHE II
³15 (n=1251) 107±21.9 110±22.6 95±19.2 107±23.9 111±22.0 104±22.3 107±23.7
<15 (n=1720) 123±19.7 111±19.3 102±14.5 114±18.7 124±19.5 110±22.0 115±13.0
Diagnostic categories
Trauma (n=247) 109±19.9 109±21.8 115±23.3 100±25.3 120±26.1 108±24.1 110±24.2
Respiratory (n=469) 115±21.7 115±24.2 102±21.0 107±23.1 109±19.1 108±24.1 110±22.2
Cardiovascular
(n=731) 124±20.9 106±22.7 102±16.2 112±20.6 116±25.1 105±20.5 119±16.7
Postoperative
(n=309) 108±13.7 99±15.9 103±14.7 77±4.2 105±13.8 98±17.8 102±15.6
Overall (n=5729) 106±25.2 99±21.4 91±16.6 98±21.8 98±19.6 99±23.9 99±22.3
*5% of the 5298 patients did not have information related to their
transfusion status. Variables reported as means±SD unless otherwise
stated. †Haemoglobin values in this table represent the pre-transfusion
values in patients receiving red cells and minimum haemoglobin values
during the ICU stay in non-transfused patients. More than one value
may be reported for a patient.acute bleeding (35%), augmentation of O2 delivery (25%),
haemodynamic instability (12%) and coronary ischaemia
(3%). Acute bleeding was most often cited when patients’
haemoglobin concentrations were less than 80g/l while
augmentation of O2 delivery was most often associated
with pre-transfusion haemoglobin concentrations greater
than 80g/l (P<0.001).
Discussion
In this study, we documented a significant interinstitu-
tional variation in pre-transfusion haemoglobin concentra-
tions and the average number of transfusions per
patient-days. Despite the widely disseminated American
College of Physicians transfusion guidelines explicitly rec-
ommending that red cells should be administered on a
unit-by-unit basis and according to clinical judgement (not
a pre-defined threshold value), a significant proportion
(40%) of critical care physicians still administer red cells at
a threshold haemoglobin concentration of 100g/l and two
units at a time.
In the multicentre cohort of critically ill patients, the insti-
tution in which patients were treated was the most power-
ful predictor of haemoglobin concentrations prior to
transfusion. A number of other investigators have
observed inter-hospital variations in the perioperative use
of red cells by examining large databases [8–11] and hospi-
tal audits [12–17]. Palermo and colleagues [10] docu-
mented a six-fold difference among institutions in
Connecticut. Others [2] have criticized these authors for
not attempting to adjust for differences in case mix
between institutions. Subsequently, other studies have
documented significant practice variation within specific
disease categories [14,17,18] and clinical settings [18]. In
the SANGUIS study [19], transfusion rates were found to
depend more on physicians than the patient population or
type of procedure or hospital. Wide variation was found
among 43 hospitals in 10 European countries [20,21] and
between hospitals within the same country [22]. Some
factors found to influence this variation were age, gender,
preoperative haematocrit and blood loss. In addition,
Hébert et al [23] documented the impact of numerous
clinical factors (eg blood loss, preoperative status, hypox-
aemia, shock, lactic acidosis) on physicians’ decisions to
transfuse their critically ill patients. There is, therefore, a
substantial body of evidence indicating that transfusion
practice varies in the perioperative period but there are
few data pertaining to the critical care setting.
After controlling for the influence of all diagnostic group-
ings, age and disease severity, a significant variation in
pre-transfusion haemoglobin concentrations from institu-
tion to institution remained. In all patients, we observed
significant interactions between APACHE II score, the
institution and transfusion status, suggesting a complex
relationship among these variables. It appeared that the
influence of APACHE II score was less pronounced in
institutions that had lower pre-transfusion haemoglobin
concentrations. By performing the same analysis in four
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Figure 1
Average pre-transfusion haemoglobin values over time in participating
institutions. This figure illustrates all haemoglobin concentrations
during the first 10 days of intensive care unit (ICU) stay. There was an
average decrease of 16g/l in haemoglobin concentrations in all
patients admitted to the ICU over the 10-day monitoring interval.
Institution 1 had the highest values over time while institution 3
recorded the lowest concentrations during the 10 days. The solid thick
line illustrates overall concentrations.
Figure 2
Average pre-transfusion haemoglobin concentrations stratified by
institution, APACHE II categories and transfusion status. Average pre-
transfusion hemoglobin concentrations stratified by transfusion status,
institution and high (>15) versus low (£15) APACHE II score.
Institution 3 and 6 had the lowest concentrations overall and patients
who received red cells [AU: Change to sentence OK?]. The influence
of APACHE II scores appeared least important in centres (3 and 6)
with a conservative approach to the administration of red cells. This
graph also illustrates significant variations in haemoglobin
concentrations in both APACHE II groups and in transfused and non-
transfused patients.representative diagnostic groupings, significant associations
between these variables and pre-transfusion haemoglobin
concentrations persisted without more complex interac-
tions. Indeed, a strong institutional effect was noted in the
four diagnostic groupings. APACHE II scores were also
associated with pre-transfusion haemoglobin concentrations
in trauma, respiratory failure and in cardiac patients.
Optimal haemoglobin concentrations in many patient pop-
ulations have been proposed by a number of authors
[21,24–27] and organizations [4–6]. Unfortunately, these
recommendations are based on clinical physiology, obser-
vational or poorly controlled clinical studies, historical
context or a belief that a particular consequence of anaemia
or transfusion is more important than another, rather than
well controlled randomized clinical trials (RCT) [28,29].
Investigators have advocated elevated haemoglobin levels
in critically ill patients [21,30,31] based on several studies
[24,25] that advocate augmenting systemic O2 delivery and
that describe the negative consequences of anaemia in crit-
ically ill patients with cardiac disease [32,33] to decrease
mortality in critically ill patients. Alternatively, a lower
transfusion threshold is supported by evidence from the
literature examining the role of transfused red cells in
immune modulation [34,35] and in microcirculatory alter-
ation [36–38]. From these studies, the liberal administra-
tion of red cells may result in increased rates of clinically
significant infections as well as organ failure and mortality.
We believe that the conflicting evidence may be one of the
many possible factors contributing to practice variation.
Recently, a large randomised controlled clinical trial in 838
critically ill patients concluded that a more restrictive trans-
fusion strategy was at least as safe and possibly superior to
a liberal strategy. Although not available at the time of this
study, data from the Transfusion Requirements in Critical
Care trial may substantially modify transfusion practive
and possibly decrease institutional and physician transfu-
sion practices. [39].
In this multicentre cohort, the major concern was the
diversity and complexity of patients. Unknown con-
founders may have accounted for the persistent institu-
tional effect noted in this study despite the use of
multivariate statistical techniques that controlled for dif-
ferences in patient characteristics.
In summary, we demonstrated a significant institutional
transfusion practice variation amongst Canadian tertiary
centres. Academic practitioners appear to have imple-
mented, only partially, well publicized transfusion guide-
lines primarily developed to address perioperative red cell
utilization. The significant variation in transfusion practice
was more pronounced in sicker patients suggesting that
both the available evidence and the derived practice
guidelines were limited for high-risk patients. We believe
that clinical trials evaluating different transfusion strate-
gies in the critically ill are required prior to the develop-
ment and dissemination of further practice guidelines in
high-risk patient populations.
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